R01 DA036865/DA/NIDA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2002	1
2003	1
2005	2
2006	1
2014	9
2015	10
2016	6
2017	8
2018	9
2019	5
2020	2
2021	2
2024	1

1

The next generation of CRISPR-Cas technologies and applications.

Pickar-Oliver A, Gersbach CA. Pickar-Oliver A, et al. Nat Rev Mol Cell Biol. 2019 Aug;20(8):490-507. doi: 10.1038/s41580-019-0131-5. Nat Rev Mol Cell Biol. 2019. PMID: 31147612 Free PMC article. Review.

2

Transgenic mice for in vivo epigenome editing with CRISPR-based systems.

Gemberling MP, Siklenka K, Rodriguez E, Tonn-Eisinger KR, Barrera A, Liu F, Kantor A, Li L, Cigliola V, Hazlett MF, Williams CA, Bartelt LC, Madigan VJ, Bodle JC, Daniels H, Rouse DC, Hilton IB, Asokan A, Ciofani M, Poss KD, Reddy TE, West AE, Gersbach CA. Gemberling MP, et al. Nat Methods. 2021 Aug;18(8):965-974. doi: 10.1038/s41592-021-01207-2. Epub 2021 Aug 2. Nat Methods. 2021. PMID: 34341582 Free PMC article.

3

Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector.

Kabadi AM, Ousterout DG, Hilton IB, Gersbach CA. Kabadi AM, et al. Nucleic Acids Res. 2014 Oct 29;42(19):e147. doi: 10.1093/nar/gku749. Epub 2014 Aug 13. Nucleic Acids Res. 2014. PMID: 25122746 Free PMC article.

4

Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.

Hilton IB, D'Ippolito AM, Vockley CM, Thakore PI, Crawford GE, Reddy TE, Gersbach CA. Hilton IB, et al. Nat Biotechnol. 2015 May;33(5):510-7. doi: 10.1038/nbt.3199. Epub 2015 Apr 6. Nat Biotechnol. 2015. PMID: 25849900 Free PMC article.

5

Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements.

Thakore PI, D'Ippolito AM, Song L, Safi A, Shivakumar NK, Kabadi AM, Reddy TE, Crawford GE, Gersbach CA. Thakore PI, et al. Nat Methods. 2015 Dec;12(12):1143-9. doi: 10.1038/nmeth.3630. Epub 2015 Oct 26. Nat Methods. 2015. PMID: 26501517 Free PMC article.

6

Mammalian Synthetic Biology: Engineering Biological Systems.

Black JB, Perez-Pinera P, Gersbach CA. Black JB, et al. Annu Rev Biomed Eng. 2017 Jun 21;19:249-277. doi: 10.1146/annurev-bioeng-071516-044649. Annu Rev Biomed Eng. 2017. PMID: 28633563 Review.

7

Synthetic transcription factors for cell fate reprogramming.

Black JB, Gersbach CA. Black JB, et al. Curr Opin Genet Dev. 2018 Oct;52:13-21. doi: 10.1016/j.gde.2018.05.001. Epub 2018 May 24. Curr Opin Genet Dev. 2018. PMID: 29803990 Review.

8

Editing the Epigenome: Reshaping the Genomic Landscape.

Holtzman L, Gersbach CA. Holtzman L, et al. Annu Rev Genomics Hum Genet. 2018 Aug 31;19:43-71. doi: 10.1146/annurev-genom-083117-021632. Epub 2018 May 31. Annu Rev Genomics Hum Genet. 2018. PMID: 29852072 Review.

9

Genome Engineering for Personalized Arthritis Therapeutics.

Adkar SS, Brunger JM, Willard VP, Wu CL, Gersbach CA, Guilak F. Adkar SS, et al. Trends Mol Med. 2017 Oct;23(10):917-931. doi: 10.1016/j.molmed.2017.08.002. Epub 2017 Sep 5. Trends Mol Med. 2017. PMID: 28887050 Free PMC article. Review.

10

Enabling functional genomics with genome engineering.

Hilton IB, Gersbach CA. Hilton IB, et al. Genome Res. 2015 Oct;25(10):1442-55. doi: 10.1101/gr.190124.115. Genome Res. 2015. PMID: 26430154 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year